Caricamento...
Lymphocyte-Activation Gene 3 (LAG3): the Next Immune Checkpoint Receptor
Immune checkpoint therapy has revolutionized cancer treatment by blocking inhibitory pathways in T cells that limits the an effective anti-tumor immune response. Therapeutics targeting CTLA-4 and PD1/PDL1 have progressed to first line therapy in multiple tumor types with some patients exhibiting tum...
Salvato in:
| Pubblicato in: | Semin Immunol |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6920665/ https://ncbi.nlm.nih.gov/pubmed/31604537 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.smim.2019.101305 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|